Biomanufacturing optimization is often slow, complex, and resource-intensive.
Virica is excited to introduce Viric.AI™, a proprietary active learning platform that expands Virica’s capabilities with a smarter, faster approach to biomanufacturing optimization.
Developed in collaboration with Dr. Francesco Gentile’s lab at the University of Ottawa, Viric.AI™ combines machine learning with iterative experimental feedback to help guide experimental design, identify high-value conditions earlier, reduce development timelines, and improve yield optimization.
The platform is already being deployed through Canada’s Pandemic Preparedness Hub (CP2H) to support adenovirus enhancer discovery, demonstrating its relevance across both commercial biomanufacturing and public health preparedness.
Viric.AI™ builds on Virica’s existing platform strengths by helping partners make better decisions earlier and move more efficiently through process development.
Read the full press release: HERE